Prevalence of Hypoparathyroidism in Australia
It is estimated that hypoparathyroidism affects approximately 1 in 2,000 people in the general population
It is estimated that hypoparathyroidism affects approximately 1 in 2,000 people in the general population
Encalaret has the potential to be a game-changing therapy for patients with hypoparathyroidism.
Encalaret is an investigational drug being studied for the treatment of hypoparathyroidism.
In this article, we'll explore some ways to improve the quality of life for sufferers
The calcium sensing receptor (CaSR) is a protein that plays a critical role in regulating
In this article, we will explore ways to manage and tackle brain fog when living
Hypoparathyroidism is a rare endocrine disorder that occurs when the parathyroid glands do not produce
CaSR Patient Support is an ACNC Registered Health Promotion Charity that aims to promote awareness,
CaSR Patient Support is an Australian charity organization that aims to raise awareness, provide knowledge,
CaSR Patient Support is an advocacy group for patients of chronic endocrine disorders involving calcium